Literature DB >> 17823803

[Treatment of wrinkles with botulinum toxin].

I Lanzl1, R-L Merté.   

Abstract

The use of botulinum toxin A for the treatment of wrinkles is increasing. Botulinum toxin A inhibits exocytosis of acetylcholine from 3 to 12 months, depending on the target tissue. Low-dose botulinum toxin A is used to smooth hyperkinetic facial lines. This is especially successful in the upper facial parts, since the target muscles (procerus, corrugator supracilii, frontalis, orbicularis oculi) all directly overlie the osseous structures of the face. This is not the case for the lower facial parts, and more side effects are encountered when treating, for example, wrinkles around the mouth. Contraindications to the use of botulinum toxin A are diseases affecting neuromuscular signal transduction, allergic reactions to components of the solution, therapy with aminoglycosides or acetylsalicylic acid prior to treatment, infections in the planned treatment area, and pregnancy and lactation. Alternative and complementary treatments include erbium-YAG or CO2 laser, as well as augmentation and surgical plastic procedures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823803     DOI: 10.1007/s00347-007-1614-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  16 in total

Review 1.  Dermal filler materials and botulin toxin.

Authors:  C Naoum; D Dasiou-Plakida
Journal:  Int J Dermatol       Date:  2001-10       Impact factor: 2.736

2.  Intraoperative injection of botulinum toxin A into orbicularis oculi muscle for the treatment of crow's feet.

Authors:  J O Guerrissi
Journal:  Plast Reconstr Surg       Date:  2000-05       Impact factor: 4.730

Review 3.  Botulinum a exotoxin for hyperfunctional facial lines: where not to inject.

Authors:  Murad Alam; Jeffrey S Dover; Arnold W Klein; Kenneth A Arndt
Journal:  Arch Dermatol       Date:  2002-09

Review 4.  Understanding botulinum toxin. Surgical anatomy of the frown, forehead, and periocular region.

Authors:  J M Wieder; R L Moy
Journal:  Dermatol Surg       Date:  1998-11       Impact factor: 3.398

Review 5.  Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin.

Authors:  A Carruthers; J Carruthers
Journal:  Dermatol Surg       Date:  1998-11       Impact factor: 3.398

6.  Botulinum toxin for palmar hyperhidrosis.

Authors:  M Naumann; P Flachenecker; E B Bröcker; K V Toyka; K Reiners
Journal:  Lancet       Date:  1997-01-25       Impact factor: 79.321

7.  Pharmacologic weakening of extraocular muscles.

Authors:  A B Scott; A Rosenbaum; C C Collins
Journal:  Invest Ophthalmol       Date:  1973-12

8.  Effect of botulinum toxin type A on movement-associated rhytides following CO2 laser resurfacing.

Authors:  T B West; T S Alster
Journal:  Dermatol Surg       Date:  1999-04       Impact factor: 3.398

9.  Treatment of blepharospasm with botulinum toxin. A preliminary report.

Authors:  B R Frueh; D P Felt; T H Wojno; D C Musch
Journal:  Arch Ophthalmol       Date:  1984-10

10.  Comparison of effects of denervation and botulinum toxin paralysis on muscle properties in mice.

Authors:  M C Brown; W G Hopkins; R J Keynes
Journal:  J Physiol       Date:  1982-06       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.